U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 47

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hodgkin lymphoma, susceptibility to, 236000, Autosomal recessive; CHL (Classic Hodgkin lymphoma) (KLHDC8B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

SmartMeds+ Pharmacogenomic Testing By Innovative GX Health

Innovative Genomics InnovativeGx Health
United States
167
  • T Targeted variant analysis

Precision HealthPGx Panel (25 Genes)

RPRD Diagnostics, LLC
United States
9723
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Whole Pharmacogenomics Scan

RPRD Diagnostics, LLC
United States
10769
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Genetic study of pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
126
  • T Targeted variant analysis

NUDT15

RPRD Diagnostics, LLC
United States
41
  • T Targeted variant analysis

NUDT15/TPMT Panel

RPRD Diagnostics, LLC
United States
42
  • T Targeted variant analysis

Tempus xT

Tempus Labs, Inc.
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

CEP72/NUDT15/TPMT Panel

RPRD Diagnostics, LLC
United States
53
  • T Targeted variant analysis

Onco microarray for CLL

Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center
United States
823
  • D Deletion/duplication analysis
  • H Detection of homozygosity

TPMT, NUDT15 gene analysis

SPMED CO., LTD Step forward Personalized Medicine
South Korea
22
  • T Targeted variant analysis

PGx-Premium (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
6627
  • T Targeted variant analysis

PGx-Standard (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
3110
  • T Targeted variant analysis

Invitae Inborn Errors of Immunity and Cytopenias Panel

Invitae
United States
755562
  • D Deletion/duplication analysis

PGmax™ - Primary Immunodeficiency and Malignancy Predisposition Panel

PreventionGenetics, part of Exact Sciences
United States
71
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pharmacogenomics SNaP-Shot

Ariel Precision Medicine
United States
126
  • T Targeted variant analysis

Thiopurines, poor metabolism of, 2, 616903, Autosomal dominant; THPM2 (Azathioprine or 6-mercatopurine toxicity or dose selection) (NUDT15 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hereditary Lymphoid/Immunodeficiency Predisposition Panel

Genetic Services Laboratory University of Chicago
United States
2766
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NUDT15 Genotyping

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia
United States
11
  • C Sequence analysis of the entire coding region

Comprehensive Hematologic Cancer Panel

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia
United States
2215
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 47

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.